Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

AVITA Medical Lowers FY2025 Sales Guidance from $100M-$106M to $67M-$81M vs $99.002M Est

Author: Benzinga Newsdesk | August 07, 2025 03:10pm
AVITA Medical (NASDAQ:RCEL) lowers FY2025 sales outlook from $100.000 million-$106.000 million to $67.000 million-$81.000 million vs $99.002 million estimate.

Posted In: RCEL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist